1-20 of 106
Borje S Andersson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bisantrene in Combination with Fludarabine and Clofarabine As Salvage Therapy for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)- an Open-Label, Phase II, Study

Ivetta Danylesko, Avichai Shimoni, Abraham Avigdor, Meirav Kedmi, Noga Shem-Tov, Ronit Yerushalmi, Maya Sasson, Dan Dominissini, Borje S. Andersson, Arnon Nagler
Journal: Blood
Blood (2023) 142 (Supplement 1): 4292.
https://doi.org/10.1182/blood-2023-178286
Published: 2023
Journal Articles

Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with T-Cell Malignancies: Final Results of a Phase I/II Trial

Chitra Hosing, Zachary Braunstein, Eric McLaughlin, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Evandro Bezzera, Gabriela Sanchez-Petitto, Sarah A Wall, Samantha M. Jaglowski, Sam Penza, Hannah Choe, Lai Wei, Robin Nakkula, Alex Cash, Richard E. Champlin, Marcos de Lima, Steven M. Devine, Dean Anthony Lee, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 184.
https://doi.org/10.1182/blood-2023-190213
Published: 2023
Journal Articles

Post-Allograft Romidepsin Maintenance Mitigates Relapse Risk and Stimulates the Graft-Versus-Malignancy Effect through Enhanced NK-Cell Cytotoxicity in Patients with Aggressive T-Cell Malignancies in a Phase I/II Trial

Chitra Hosing, Eric McLaughlin, Zachary Braunstein, Benigno C Valdez, Lai Wei, Uday R Popat, Borje S Andersson, Sumithira Vasu, Karilyn T. Larkin, Samantha Jaglowski, Sam Penza, Ayman Saad, Hannah Choe, Sarah A Wall, Alex Cash, Robin Nakkula, Richard E Champlin, Marcos J.G. de Lima, Dean Anthony Lee, Jonathan E Brammer
Journal: Blood
Blood (2022) 140 (Supplement 1): 1885–1886.
https://doi.org/10.1182/blood-2022-169336
Published: 2022
Journal Articles

High Efficacy of the PARP Inhibitor Olaparib Combined with High-Dose Chemotherapy and Autologous Stem-Cell Transplant for Refractory Lymphomas

Yago Nieto, Benigno C Valdez, Peter F Thall, Jeremy L. Ramdial, Samer A Srour, Chitra Hosing, Neeraj Saini, Amin M Alousi, Muzaffar H Qazilbash, Uday R Popat, Alison Gulbis, Terri Lynn Shigle, Roland Bassett, Maria Guillermo-Pacheco, Celina Ledesma, Paolo Strati, Sairah Ahmed, Raphael Steiner, Jason Westin, Ranjit Nair, Swaminathan P. Iyer, Richard E Champlin, Elizabeth J Shpall, Borje S Andersson
Journal: Blood
Blood (2022) 140 (Supplement 1): 1183–1184.
https://doi.org/10.1182/blood-2022-156121
Published: 2022
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial

Uday R. Popat, Roland Bassett, Peter F. Thall, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Naval Daver, Farhad Ravandi, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson, Rohtesh S. Mehta
Journal: Blood
Blood (2021) 138 (Supplement 1): 556.
https://doi.org/10.1182/blood-2021-152450
Published: 2021
Journal Articles

Romidepsin in Conditioning and Maintenance Mitigates Relapse Risk and Enhances NK-Cell Cytotoxicity in Patients Receiving Allogeneic Stem Cell Transplant for Aggressive T-Cell Malignancies: Results of a Phase I/II Clinical Trial

Chitra Hosing, Zachary Braunstein, Alaa M Ali, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Karilyn Larkin, Sam Penza, Hannah Choe, Ayman Saad, Marcos J.G. de Lima, Lai Wei, Eric McLaughlin, Robin Nakkula, Amanda Campbell, Prashant Trikha, Marcin Puto, Basem M. William, Richard E. Champlin, Dean Anthony Lee, Jonathan E Brammer
Journal: Blood
Blood (2021) 138 (Supplement 1): 553.
https://doi.org/10.1182/blood-2021-152833
Published: 2021
Journal Articles

Optimizing Myeloablative Fractionated Busulfan, Fludarabine and Thiotepa Regimen: Results of Two Parallel Cohorts in a Phase 2 Prospective Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Katayoun Rezvani, Muzaffar H. Qazilbash, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1802.
https://doi.org/10.1182/blood-2021-146655
Published: 2021
Journal Articles

Post-Transplant Cyclophosphamide Versus Tacrolimus and Methotrexate to Prevent Graft-Versus-Host Disease in Recipients of Matched Donor Transplantation: Comparison of Sequential Cohorts in a Prospective Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Hagop Kantarjian, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1803.
https://doi.org/10.1182/blood-2021-146245
Published: 2021
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Venetoclax in Patients with AML/MDS: Prospective Phase II Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Alison Gulbis, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Marina Konopleva, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2879.
https://doi.org/10.1182/blood-2021-146253
Published: 2021
Journal Articles

Combination of Cord Blood T Regulatory Cells with Ruxolitinib Decreases Side Effects and Improves Survival in Xenogenic Graft Vs. Host Disease

Ke Zeng, MD, Meixian Huang, MD,PhD, Li Li, MD, Mi-Ae Lyu, PhD, Hongbing Ma, MD, Mitsutaka Nishimoto, MD,PhD, Tara Sadeghi, Sairah Ahmed, MD, Borje S. Andersson, MD, PhD, Simrit Parmar, MD, MSCI
Journal: Blood
Blood (2020) 136 (Supplement 1): 2.
https://doi.org/10.1182/blood-2020-140417
Published: 2020
Journal Articles

A Randomized Study of Pretransplant Conditioning Therapy for AML/MDS with Fludarabine ± Clofarabine and Once Daily IV Busulfan with Allogeneic Hematopoietic Transplantation for AML and MDS

Borje S. Andersson, MD, PhD, Peter Thall, Benigno C. Valdez, PhD, Junsheng Ma, MS, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Alison Gulbis, Chitra Hosing, MD, Roy B. Jones, MD PhD, Jitesh Kawedia, BPharm, Partow Kebriaei, MD, Steven M. Kornblau, MD, Alan Myers, PharmD, PhD RPh, Betul Oran, MDMS, Katayoun Rezvani, MD PhD, Nina Shah, MD, Elizabeth J. Shpall, MD, Simrit Parmar, MD, MSCI, Uday R. Popat, MD, Yago Nieto, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-142680
Published: 2020
Journal Articles

High-Dose Chemotherapy (HDC) with Autologous Stem-Cell Transplant (ASCT) with Consolidative Radiation Therapy (RT) for Relapsed or Refractory (R/R) Primary Mediastinal B-Cell Lymphoma (PMBCL): 20-Year Experience at MD Anderson Cancer Center (MDACC)

Neeraj Saini, MD, Junsheng Ma, MS, Melissa Timmons, PA-C, Amin M. Alousi, MD, Paolo Anderlini, Borje S. Andersson, MD, PhD, Chitra Hosing, MD, Jeremy Ramdial, MD, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Elizabeth J. Shpall, MD, Samer A. Srour, MD MS, Benigno C. Valdez, PhD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Yago Nieto, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-134471
Published: 2020
Journal Articles

Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience

Yago Nieto, MD, Stephen K. Gruschkus, PhD MPH, Roy B. Jones, MD PhD, Benigno C. Valdez, PhD, Melissa Timmons, PA-C, Chitra Hosing, MD, Paolo Anderlini, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Amin M. Alousi, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Jin S. Im, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD, Alison Gulbis, Terri Lynn Shigle, PharmD, Kris Michael Mahadeo, MD, Sajad Khazal, MD, Issa F. Khouri, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Hun Lee, MD, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Swaminathan P Iyer, MD, Ranjit Nair, MD, Simrit Parmar, MD, MSCI, Branko Cuglievan, MD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Borje S. Andersson, MD, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-139880
Published: 2020
Journal Articles

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Rohtesh S. Mehta, MDMPH,MS, Roland Bassett, Julianne Chen, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Amin M. Alousi, MD, Gheath Alatrash, Qaiser Bashir, MD, Stefan Ciurea, MD, Chitra Hosing, MD, Jin S. Im, Partow Kebriaei, MD, Amanda L. Olson, Betul Oran, MDMS, Muzaffar H. Qazilbash, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Borje S. Andersson, MD, PhD, Richard E. Champlin, MD, Uday R. Popat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-139325
Published: 2020
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study

Uday Popat, MD, Rohtesh S. Mehta, MD, Roland Bassett, Amanda L. Olson, MD, Julianne Chen, Christina Ganesh, BSN, RN, Amin M. Alousi, MD, Paolo Anderlini, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, Chitra Hosing, MD, Jin S Im, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, MD, David Marin, MD, Yago Nieto, MD PhD, Betul Oran, MDMS, Neeraj Saini, MD, Samer Srour, Katayoun Rezvani, MD PhD, Muzaffar Qazilbash, Jeffrey J. Molldrem, Elizabeth J. Shpall, MD, Borje S Andersson, MD PhD, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 256.
https://doi.org/10.1182/blood-2019-122124
Published: 2019
Journal Articles

A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS

Richard E. Champlin, MD, Uday Popat, MD, Betul Oran, MDMS, Stefan O. Ciurea, MD, Partow Kebriaei, MD, Amin M. Alousi, MD, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Issa F. Khouri, MD, Chitra Hosing, MD, Paolo Anderlini, Roy B Jones, MD PhD, David Marin, MD, Rohtesh Mehta, MD, Yago Nieto, MD PhD, Amanda L. Olson, MD, Muzaffar H. Qazilbash, MD, Katy Rezvani, MD PhD, Elizabeth J. Shpall, MD, Julianne Chen, Gabriela Rondon, MD, Becky McMullin, Vivian P Al Jahdhami, RN, Jitesh Kawedia, BPharm, Benigno C. Valdez, PhD, Junsheng Ma, MS, Peter F Thall, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 257.
https://doi.org/10.1182/blood-2019-124921
Published: 2019
Journal Articles

Decitabine As Part of a Modified Bu-Cy Conditioning Regimen Significantly Improved the Outcome of High-Risk AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Xiaowen Tang, Benigno C. Valdez, PhD, Qianqian Zhang, Yunju Ma, Haiping Dai, Jia Yin, Zheng Li, Ting Xu, Yang Xu, MD PhD, Jia Chen, Xiaming Zhu, Depei Wu, MD PhD, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3270.
https://doi.org/10.1182/blood-2019-123951
Published: 2019
Journal Articles

Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receiving Myeloablative Fractionated Busulfan Conditioning Regimen

Uday Popat, MD, Rima M. Saliba, PhD, Rohtesh S. Mehta, MD, Amanda L. Olson, MD, Julianne Chen, Christina Ganesh, BSN, RN, Gabriela Rondon, MD, Glenda Woodworth, BSN, OCN, RN, Becky McMullin, Amin M. Alousi, MD, Paolo Anderlini, Gheath Alatrash, DO, PhD, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, Chitra Hosing, MD, Jin S Im, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, MD, David Marin, MD, Yago Nieto, MD PhD, Betul Oran, MDMS, Neeraj Saini, MD, Samer Srour, Katayoun Rezvani, MD PhD, Muzaffar H. Qazilbash, MD, Jeffrey J. Molldrem, Elizabeth J. Shpall, MD, Borje S Andersson, MD PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3296.
https://doi.org/10.1182/blood-2019-125996
Published: 2019
Journal Articles

Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial

Ke Zeng, MD PhD, Hongbing Ma, MD PhD, Uday Popat, MD, Yago Nieto, MD PhD, Stefan O. Ciurea, MD, Amanda L. Olson, MD, Mi-Ae Lyu, PhD, Meixian Huang, Mitsutaka Nishimoto, MD PhD, Muzaffar H. Qazilbash, MD, Jennifer D Ramos, RN, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Simrit Parmar, MBBS, Borje S Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4547.
https://doi.org/10.1182/blood-2019-127726
Published: 2019
Journal Articles

Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

Amanda L. Olson, MD, Ruitao Lin, Mustafa Bdaiwi, MD, Peter F Thall, Hind Rafei, MD, Indreshpal Kaur, PhD, Li Li, MD, Glorette Abueg, Melissa Timmons, Roy Chemaly, MD PhD, David Marin, MD, Amin M. Alousi, MD, Sairah Ahmed, MD, Stefan O. Ciurea, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Roy B Jones, MD PhD, Borje S Andersson, MD PhD, Betul Oran, MDMS, Ala Abuddayeh, Uday Popat, MD, Richard E. Champlin, MD, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3596.
https://doi.org/10.1182/blood-2019-126028
Published: 2019